ANSA BIOTECHNOLOGIES
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.
ANSA BIOTECHNOLOGIES
Industry:
Biotechnology Life Science Therapeutics
Founded:
2018-05-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.ansabio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
83.42 M USD
Technology used in webpage:
Amazon U.S. Server Location
Similar Organizations
Aikium Inc.
Deep Learning x Synthetic Biology for Novel Protein Therapeutics
Alga Biosciences
Alga Biosciences is eliminating enteric methane emissions at scale.
Aquacycl
Aquacycl provides bioelectrochemical technologies to address global challenges.
IsoSpec Analytics
IsoSpec Analytics accurate molecular biometrics for faster drug and biomarker discovery.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Photonic
Photonic is at the forefront of designing next-generation quantum technologies in silicon.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Humboldt Fund
Humboldt Fund investment in Series A - Ansa Biotechnologies
RA Capital Management
RA Capital Management investment in Series A - Ansa Biotechnologies
Fifty Years
Fifty Years investment in Series A - Ansa Biotechnologies
Peak 6
Peak 6 investment in Series A - Ansa Biotechnologies
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series A - Ansa Biotechnologies
Fiscus Ventures
Fiscus Ventures investment in Series A - Ansa Biotechnologies
Northpond Ventures
Northpond Ventures investment in Series A - Ansa Biotechnologies
Horizons Ventures
Horizons Ventures investment in Series A - Ansa Biotechnologies
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series A - Ansa Biotechnologies
Carbon Silicon Ventures
Carbon Silicon Ventures investment in Series A - Ansa Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.ansabio.com Semrush global rank: 5.49 M Semrush visits lastest month: 1.34 K
- Host name: 115.68.215.35.bc.googleusercontent.com
- IP address: 35.215.68.115
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Ansa Biotechnologies"
Company | Ansa Biotechnologies
Our Mission and Vision At Ansa Biotechnologies, we’ve established a new way to manufacture synthetic DNA that overcomes the limitations of traditional DNA synthesis methods. We …See details»
Ansa Biotechnologies - Crunchbase Company Profile & Funding
Contact Email [email protected] Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa …See details»
Ansa Biotechnologies, Inc. | LinkedIn
Https://ansabio.com 66 1 Comment Like Comment Share Ansa Biotechnologies, Inc. 7,741 followers 2w Report this post We are excited to announce the availability of our 5 kb clonal product! ...See details»
Ansa Biotechnologies - Overview, News & Similar companies
Feb 22, 2024 View Ansa Biotechnologies (www.ansabio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
ANSA BIOTECHNOLOGIES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANSA BIOTECHNOLOGIES, INC. of Emeryville, CA. Get the latest business insights from Dun & …See details»
Ansa Biotechnologies Appoints Jason T. Gammack as …
Feb 22, 2024 Gammack is joining the company as it completes its early access program and prepares for a full commercial launch of its rapid enzymatic synthesis for complex clonal genes and gene fragments. Founding CEO Dan …See details»
Ansa Biotechnologies Raises $9.2 Million in Combined …
Sep 14, 2020 For more information, visit ansabio.com or follow on Twitter and LinkedIn. About Horizons Ventures . Horizons Ventures, the private investment arm of Mr. Li Ka-shing, is a leading investor in some ...See details»
Ansa Biotechnologies Appoints Jason T. Gammack as CEO and
Feb 22, 2024 EMERYVILLE, Calif.--(BUSINESS WIRE)-- Ansa Biotechnologies, Inc., a pioneer of next-generation DNA synthesis, today announced the appointment of Jason T. Gammack …See details»
Ansa Biotechnologies - Work in biotech
Ansa Biotechnologies is discovering more sustainable and accurate ways of synthesizing DNA. Currently, DNA is manufactured using a chemical method for various downstream applications …See details»
Ansa Biotechnologies Expands Leadership Team with …
Aug 23, 2022 For partnering inquiries or information about Ansa’s early access program, email [email protected]. Contacts. Kimberly Ha KKH Advisors 917-291-5744 [email protected].See details»
Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis …
EMERYVILLE, Calif., July 30, 2024--Ansa Biotechnologies announced the commercial availability of its Ansa Clonal DNA and Ansa DNA Fragments.See details»
Ansa Biotechnologies Closes Oversubscribed $68 Million Series A ...
Apr 11, 2022 For partnering inquiries or information about Ansa’s early access program, email [email protected]. Contacts. Kimberly Ha KKH Advisors 917-291-5744 …See details»
Press Release Service: Ansa Biotechnologies Appoints Jason T.
Feb 22, 2024 Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA SequencesSee details»
Ansa Biotechnologies Announces First Shipments of Complex
May 22, 2023 EMERYVILLE, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies, Inc., a pioneer of next-generation DNA synthesis, today announced that it has synthesized and delivered …See details»
Frequently Asked Questions | Ansa Biotechnologies
Once you have an acceptable quote, there are two ways to place an order: Log into your account at portal.ansabio.com, select the quote you would like to purchase and follow the instructions …See details»
Ansa Biotechnologies to Showcase Early Access Customer Success …
EMERYVILLE, Calif., April 30, 2024--Ansa Biotechnologies announced its speaker lineup for presentations at the upcoming SynBioBeta Conference.See details»
Ansa Biotechnologies Expands Successful Early Access Program for ...
May 6, 2024 Ansa Biotechnologies is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to take advantage of …See details»
Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis …
Jul 29, 2024 250 First Avenue, Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 E: [email protected]See details»
News & Events | Ansa Biotechnologies
Combining its complex DNA synthesis platform with a unique long-read sequencing and analysis approach for quality control allows Ansa to produce long, complex DNA more accurately and …See details»